Sanggenol H exhibits significant anti-inflammatory and antioxidant activities, making it a promising candidate for use in pharmaceutical and nutraceutical formulations. It has been studied for its potential to inhibit pro-inflammatory cytokines and modulate signaling pathways such as NF-κB, which plays a key role in chronic inflammatory diseases. Due to its ability to reduce oxidative stress, Sanggenol H may be useful in developing treatments for neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. Additionally, it shows antitumor properties by inducing apoptosis in certain cancer cell lines, suggesting applications in oncology research. Its natural origin and bioactivity also support its use in cosmetic products aimed at skin protection and anti-aging.